Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
405.55 M EUR
2.40 B EUR
342.12 M
About NOVONESIS (NOVOZYMES A/S) B
Sector
CEO
Ester Baiget
Headquarters
Lyngby
Website
ISIN
DK0060336014
FIGI
BBG00KDZJQK3
Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NZYM is 57.10 EUR — it has increased by 3.74% in the past 24 hours. Watch NOVOZYMES AS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange NOVOZYMES AS stocks are traded under the ticker NZYM.
NZYM stock has risen by 5.51% compared to the previous week, the month change is a −4.74% fall, over the last year NOVOZYMES AS has showed a 17.66% increase.
We've gathered analysts' opinions on NOVOZYMES AS future price: according to them, NZYM price has a max estimate of 78.56 EUR and a min estimate of 48.80 EUR. Watch NZYM chart and read a more detailed NOVOZYMES AS stock forecast: see what analysts think of NOVOZYMES AS and suggest that you do with its stocks.
NZYM reached its all-time high on Jan 3, 2022 with the price of 72.76 EUR, and its all-time low was 35.86 EUR and was reached on Jan 25, 2019. View more price dynamics on NZYM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NZYM stock is 3.73% volatile and has beta coefficient of 0.41. Track NOVOZYMES AS stock price on the chart and check out the list of the most volatile stocks — is NOVOZYMES AS there?
Today NOVOZYMES AS has the market capitalization of 26.52 B, it has increased by 2.32% over the last week.
Yes, you can track NOVOZYMES AS financials in yearly and quarterly reports right on TradingView.
NOVOZYMES AS is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
NZYM earnings for the last quarter are 0.36 EUR per share, whereas the estimation was 0.51 EUR resulting in a −30.34% surprise. The estimated earnings for the next quarter are 0.66 EUR per share. See more details about NOVOZYMES AS earnings.
NOVOZYMES AS revenue for the last quarter amounts to 1.02 B EUR, despite the estimated figure of 1.01 B EUR. In the next quarter, revenue is expected to reach 993.33 M EUR.
NOVOZYMES AS dividend yield was 1.67% in 2023, and payout ratio reached 56.80%. The year before the numbers were 1.71% and 45.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 24, 2024, the company has 6.76 K employees. See our rating of the largest employees — is NOVOZYMES AS on this list?
Like other stocks, NZYM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVOZYMES AS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVOZYMES AS technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVOZYMES AS stock shows the buy signal. See more of NOVOZYMES AS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.